Article Details

Roche's Tecentriq is the first IO drug to claim a post-surgery win in lung cancer. But will doctors use ...

Retrieved on: 2021-03-22 14:37:30

Tags for this article:

Click the tags to see associated articles and topics

Roche's Tecentriq is the first IO drug to claim a post-surgery win in lung cancer. But will doctors use .... View article details on hiswai:

Excerpt

When used after surgery, Roche's Tecentriq prevented cancer recurrence or death among patients with stage II to IIIA non-small cell lung cancer, the ...

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up